Pandion Stock

www.pandionpro.com/Industrial / LogisticsFounded: 2020

Pandion, founded in 2017, is a biotechnology company striving to create and advance novel therapeutics to treat autoimmune and inflammatory diseases. Leveraging its modular immune effector platform, Pandion is aiming to unlock the potential of bispecific therapeutics. The company's mission is to develop transformative therapies that can restore immune system balance and improve the lives of patients. Pandion is based in Cambridge, Massachusetts.

Register for Details

For more details on financing and valuation for Pandion, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in

OverviewFinancingsValuation

Enterprise Value (based on primary financings)

Powered by Forge Data
Enterprise Value

View Enterprise Value for Pandion.

Register Today

Team

Management Team

Scott Ruffin
Founder & Chief Executive Officer

Other companies like Pandion in the Logistics sector

Sector
Last Round Est. Valuation
$4.16B
Sector
Last Round Est. Valuation
$3.8B
Sector
Last Round Est. Valuation
$483.91MM
Sector
Last Round Est. Valuation
$385.02MM
Sector
Last Round Est. Valuation
$2.46B
Sector
Last Round Est. Valuation
$1.01B
Sector
Last Round Est. Valuation
$173.81MM
Sector
Last Round Est. Valuation
$1.02B
Sector
Last Round Est. Valuation
$401.33MM
Updated on: Oct 3, 2023

PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES

Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.